Cargando…
Steroid harms if given early in COVID-19 viraemia
COVID-19 is a biphasic illness with an initial viraemia phase and later effective adaptive immune phase, except in a minority of people who develop severe disease. Immune regulation is the key target to treat COVID illness. In anticipation, an elderly man self-medicated himself with dexamethasone on...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868223/ https://www.ncbi.nlm.nih.gov/pubmed/33541971 http://dx.doi.org/10.1136/bcr-2020-241105 |
_version_ | 1783648417190248448 |
---|---|
author | Arora, Kanupriya Panda, Prasan Kumar |
author_facet | Arora, Kanupriya Panda, Prasan Kumar |
author_sort | Arora, Kanupriya |
collection | PubMed |
description | COVID-19 is a biphasic illness with an initial viraemia phase and later effective adaptive immune phase, except in a minority of people who develop severe disease. Immune regulation is the key target to treat COVID illness. In anticipation, an elderly man self-medicated himself with dexamethasone on the day of symptom onset of a flu-like illness, took other symptomatic measures and was tested positive for SARS-CoV-2. His condition deteriorated with each passing day resulting in hospitalisation. He demanded oxygen and declared as severe COVID. With supportive treatment, he recovered after the 20th day of illness. Immunosuppression and anti-inflammation are likely to benefit when the immune response is dysregulated and turning into a cytokine storm. A medication that has saved many could be the one predisposing to severity if taken as a preventive measure, too early in the disease course, especially the viraemia phase. |
format | Online Article Text |
id | pubmed-7868223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-78682232021-02-16 Steroid harms if given early in COVID-19 viraemia Arora, Kanupriya Panda, Prasan Kumar BMJ Case Rep Case Report COVID-19 is a biphasic illness with an initial viraemia phase and later effective adaptive immune phase, except in a minority of people who develop severe disease. Immune regulation is the key target to treat COVID illness. In anticipation, an elderly man self-medicated himself with dexamethasone on the day of symptom onset of a flu-like illness, took other symptomatic measures and was tested positive for SARS-CoV-2. His condition deteriorated with each passing day resulting in hospitalisation. He demanded oxygen and declared as severe COVID. With supportive treatment, he recovered after the 20th day of illness. Immunosuppression and anti-inflammation are likely to benefit when the immune response is dysregulated and turning into a cytokine storm. A medication that has saved many could be the one predisposing to severity if taken as a preventive measure, too early in the disease course, especially the viraemia phase. BMJ Publishing Group 2021-02-04 /pmc/articles/PMC7868223/ /pubmed/33541971 http://dx.doi.org/10.1136/bcr-2020-241105 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Case Report Arora, Kanupriya Panda, Prasan Kumar Steroid harms if given early in COVID-19 viraemia |
title | Steroid harms if given early in COVID-19 viraemia |
title_full | Steroid harms if given early in COVID-19 viraemia |
title_fullStr | Steroid harms if given early in COVID-19 viraemia |
title_full_unstemmed | Steroid harms if given early in COVID-19 viraemia |
title_short | Steroid harms if given early in COVID-19 viraemia |
title_sort | steroid harms if given early in covid-19 viraemia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868223/ https://www.ncbi.nlm.nih.gov/pubmed/33541971 http://dx.doi.org/10.1136/bcr-2020-241105 |
work_keys_str_mv | AT arorakanupriya steroidharmsifgivenearlyincovid19viraemia AT pandaprasankumar steroidharmsifgivenearlyincovid19viraemia |